Globus Medical, Inc.

Informe acción NYSE:GMED

Capitalización de mercado: US$6.7b

Globus Medical Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dan Scavilla

Chief Executive Officer (CEO)

US$3.8m

Compensación total

Porcentaje del salario del CEO11.4%
Permanencia del CEO2.1yrs
Participación del CEOn/a
Permanencia media de la dirección5.1yrs
Promedio de permanencia en la Junta Directiva5yrs

Actualizaciones recientes de la dirección

Recent updates

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

May 06
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Mar 14
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth

Mar 01

Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Feb 24
Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Feb 08
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jan 21
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Nov 28
Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Nov 10
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Oct 19
At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Dan Scavilla en comparación con los beneficios de Globus Medical?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

US$123m

Sep 30 2023n/an/a

US$158m

Jun 30 2023n/an/a

US$204m

Mar 31 2023n/an/a

US$201m

Dec 31 2022US$4mUS$437k

US$190m

Sep 30 2022n/an/a

US$155m

Jun 30 2022n/an/a

US$155m

Mar 31 2022n/an/a

US$142m

Dec 31 2021US$2mUS$396k

US$149m

Sep 30 2021n/an/a

US$187m

Jun 30 2021n/an/a

US$184m

Mar 31 2021n/an/a

US$122m

Dec 31 2020US$2mUS$384k

US$102m

Sep 30 2020n/an/a

US$95m

Jun 30 2020n/an/a

US$89m

Mar 31 2020n/an/a

US$148m

Dec 31 2019US$2mUS$366k

US$155m

Sep 30 2019n/an/a

US$146m

Jun 30 2019n/an/a

US$143m

Mar 31 2019n/an/a

US$150m

Dec 31 2018US$2mUS$355k

US$156m

Sep 30 2018n/an/a

US$144m

Jun 30 2018n/an/a

US$134m

Mar 31 2018n/an/a

US$118m

Dec 31 2017US$1mUS$345k

US$107m

Compensación vs. Mercado: La compensación total de Dan($USD3.82M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD8.28M).

Compensación vs. Ingresos: La compensación de Dan ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Dan Scavilla (58 yo)

2.1yrs

Permanencia

US$3,818,318

Compensación

Mr. Daniel T. Scavilla, also known as Dan, serves as President and Chief Executive Officer at Globus Medical, Inc. since April 21, 2022 and serves as its Director since April 2022. He had been Executive Vi...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
David Paul
Co-Founder & Executive Chairman21.3yrsUS$3.22m16.48%
$ 1.1b
Daniel Scavilla
President2.1yrsUS$3.82msin datos
Keith Pfeil
CFO & COO4.8yrsUS$1.49m0%
$ 0
Brian Kearns
Senior Vice President of Business Development & Investor Relationsno datasin datossin datos
Kelly Huller
Senior VP5.4yrsUS$1.15m0%
$ 0

5.1yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de GMED es experimentado (5 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
David Paul
Co-Founder & Executive Chairman21.3yrsUS$3.22m16.48%
$ 1.1b
Daniel Scavilla
President2.1yrsUS$3.82msin datos
Ann Rhoads
Independent Director12.8yrsUS$391.84k0.017%
$ 1.1m
John DeFord
Independent Directorless than a yearsin datos0.012%
$ 775.3k
Stephen Zarrilli
Independent Director5yrsUS$371.84k0%
$ 0
James Tobin
Independent Director8.8yrsUS$379.34k0%
$ 0
Daniel Wolterman
Independent Directorless than a yearsin datos0.018%
$ 1.2m
Robert Douglas
Independent Director4.4yrsUS$371.84k0.0015%
$ 99.5k
David Davidar
Independent Director21.2yrsUS$369.34k0.59%
$ 39.4m
Leslie Norwalk
Independent Directorless than a yearsin datos0.013%
$ 867.4k
Daniel Lemaitre
Independent Director13.1yrsUS$379.34k0.0080%
$ 538.0k

5.0yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de GMED se considera experimentada (4.9 años de antigüedad promedio).